Vision In Nhanes

2006年，我们使用NHANES全国调查数据来估计美国由于未经矫正的屈光不正造成的视力损害的程度(JAMA 2006；295：2158-2163)。我们随后对美国的屈光矫正成本进行了分析，意识到许多人已经进行了屈光矫正(例如眼镜或隐形眼镜)，而其他人需要新的或更好的屈光矫正(例如新的眼镜或新的隐形眼镜处方)才能让他们看得更好。保守地说，每年矫正视力障碍的直接成本为40亿美元，其中10亿美元是为有需要的人提供第一副眼镜所需的成本。2008年，我们使用NHANES数据调查了12岁及以上美国人屈光不正的影响。 作为这些论文的补充，分析了国家健康访谈调查的数据，以确定美国成年人报告的与年龄相关的眼部疾病的程度和视力损害的程度。此外，我们还采用焦点小组讨论的方法，调查了影响个人寻求预防性眼科护理服务的因素。我们的发现表明，患者和他们的初级卫生保健提供者之间的沟通可以促进改善获得眼部保健的机会。 NHANES视网膜数据(2005-2008年在疾病控制和预防中心的支持下收集)也向公众开放。在2010年NHANES对40岁以上患有糖尿病的成年人的数据分析中，据估计，近32%的男性和26%的女性患有糖尿病视网膜病变。 许多科学论文来自对NHANES数据的分析，包括推导出对程度的估计，并描述了由于屈光不正和眼病造成的视力损害的影响。NHANES数据还被用于监测视力和眼睛健康方面的差异。考虑到NHANES数据的广泛排列，眼睛数据已经与健康、疾病和功能损害的非眼部指标一起进行了分析。

In 2006 we used the NHANES national survey data to estimate the extent of visual impairment in the United States due to uncorrected refractive error (JAMA 2006;295:2158-2163). We subsequently followed up with an analysis of the cost of refractive correction in the United States realizing that many people already have refractive correction (e.g. eyeglasses or contacts lenses) and others need new or better refractive correction (e.g. a new pair of eyeglasses or a new contact lens prescription) to allow them to see well. Conservatively, the annual direct cost of correcting visual impairment is $4 billion per year, of which $1 billion represents the cost required to provide an initial set of glasses to those in need. In 2008 we investigated, using the NHANES data, the impact of refractive error in Americans ages 12 and older. As an adjunct to these papers, data from the National Health Interview Survey were analyzed to determine the extent of age-related eye diseases and degree of visual impairment reported by American adults. In addition, using focus group discussions, we investigated the factors which influence individuals to seek out preventive eye care services. Our findings indicate that communication between patients and their primary health care providers could facilitate improved access to eye care. NHANES retinal data (collected in 2005-2008 with the support of the Centers for Disease Control and Prevention) are also available to the public. In a 2010 analysis of NHANES data on adults over age 40 with diabetes, almost 32% of men and 26% of women, were estimated to have diabetic retinopathy. Numerous scientific papers have resulted from analyses of the NHANES data, including deriving estimates on the magnitude and describing the impact of visual impairment due to refractive errors and to eye disease. NHANES data have also been used for surveillance of disparities in vision and eye health. Given the wide array of NHANES data, the eye data has been analyzed in conjunction with non-ocular indicators of health, disease, and functional impairment.